PT - JOURNAL ARTICLE AU - Woolley, Ann E. AU - Dryden-Peterson, Scott AU - Kim, Andy AU - Naz-McLean, Sarah AU - Kelly, Christina AU - Laibinis, Hannah H. AU - Bagnall, Josephine AU - Livny, Jonathan AU - Ma, Peijun AU - Orzechowski, Marek AU - Shoresh, Noam AU - Gabriel, Stacey AU - Hung, Deborah T. AU - Cosimi, Lisa A. TI - At-home Testing and Risk Factors for Acquisition of SARS-CoV-2 Infection in a Major US Metropolitan Area AID - 10.1101/2022.02.02.22269258 DP - 2022 Jan 01 TA - medRxiv PG - 2022.02.02.22269258 4099 - http://medrxiv.org/content/early/2022/02/03/2022.02.02.22269258.short 4100 - http://medrxiv.org/content/early/2022/02/03/2022.02.02.22269258.full AB - Importance Unbiased assessment of risks associated with acquisition of SARS-CoV-2 is critical to informing mitigation efforts during pandemics.Objective Understand risk factors for acquiring COVID-19 in a large, prospective cohort of adult residents recruited to be representative of a large US metropolitan area.Design Fully remote longitudinal cohort study launched in October 2020 and ongoing; Study data reported through June 15, 2021.Setting Brigham and Women’s Hospital, Boston MA.Participants Adults within 45 miles of Boston, MA.Intervention Monthly at-home SARS-CoV-2 viral and antibody testing.Main Outcomes Between October 2020 and January 2021, we enrolled 10,289 adults reflective of Massachusetts census data. At study entry, 567 (5.5%) participants had evidence of current or prior SARS-CoV-2 infection. This increased to 13.4% by June 15, 2021. Compared to whites, Black non-Hispanic participants had a 2.2 fold greater risk of acquiring COVID-19 (HR 2.19, 95% CI 1.91-2.50; p=<0.001) and Hispanics had a 1.5 fold greater risk (HR 1.52, 95% CI 1.32-1.71; p=<0.016). Individuals aged 18-29, those who worked outside the home, and those living with other adults and children were at an increased risk. Individuals in the second and third lowest disadvantaged neighborhood communities, as measured by the area deprivation index as a marker for socioeconomic status by census block group, were associated with an increased risk in developing COVID-19. Individuals with medical risk factors for severe COVID-19 disease were at a decreased risk of SARS-CoV-2 acquisition.Conclusions These results demonstrate that race/ethnicity and socioeconomic status are not only risk factors for severity of disease but are also the biggest determinants of acquisition of infection. Importantly, this disparity is significantly underestimated if based on PCR data alone as noted by the discrepancy in serology vs. PCR detection for non-white participants, and points to persistent disparity in access to testing. Meanwhile, medical conditions and advanced age that increase the risk for severity of SARS-CoV-2 disease were associated with a lower risk of acquisition of COVID-19 suggesting the importance of behavior modifications. These findings highlight the need for mitigation programs that overcome challenges of structural racism in current and future pandemics.Trial Registration N/AQuestion What population and occupational groups in the United States are at increased risk for acquiring COVID-19?Findings In this remote, longitudinal cohort study involving monthly PCR and serology self-testing of 10,289 adult residents of the Boston metropolitan area, 9257 (90.0%) of TestBoston participants acquired evidence of immunity to SARS-CoV-2 through vaccination, infection, or both as of June 15, 2021. Residents identifying as Black, Hispanic/Latinx had an increased risk of acquisition of COVID-19. Healthcare workers were not at increased risk of SARS-CoV-2 acquisition. Individuals with medical risk factors for severe COVID-19 disease were at a decreased risk of SARS-CoV-2 acquisition.Meaning These results demonstrate that race/ethnicity and socioeconomic status are not only risk factors for severity of disease but also are the biggest determinants of acquisition of infection. These findings highlight the need to address the consequences of structural racism during the development of mitigation programs for current and future pandemics.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by Brigham and Womens Hospital COVID Response Fund, the Klarman Family Foundation, Skoll Foundation, ThermoFisher, the Helgeson Family Foundation, additional anonymous funders, as well as the Harvard University Center for AIDS Research (CFAR), a funded program of the National Institutes of Health (P30 AI060354).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of Mass General Brigham gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.